共 49 条
[1]
Levin A(2006)Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 31-38
[2]
Bakris GL(2013)CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis Clin J Am Soc Nephrol 8 2132-2140
[3]
Molitch M(2005)Calcification and cardiovascular problems in renal failure Kidney Int 67 S120-S127
[4]
Smulders M(2009)KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int Suppl 113 S1-130
[5]
Tian J(2010)Reduced hepatic synthesis of calcidiol in uremia J Am Soc Nephrol 21 1488-1497
[6]
Williams LA(2006)Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure J Am Soc Nephrol 17 3041-3048
[7]
Andress DL(2015)Effect of parathyroidectomy on vitamin D levels World J Surg 39 1333-1334
[8]
Block GA(2006)A long-term comparative study of calcitriol versus alphacalcidol in patients with secondary hyperparathyroidism on hemodialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 26 226-233
[9]
Kilpatrick RD(2008)Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial Can J Clin Pharm 15 e36-e43
[10]
Lowe KA(2011)Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients Nephrology 16 277-284